Monday, 3 June 2019

Merck wins U.S. FDA approval for expanded use of antibiotic

The U.S. Food and Drug Administration on Monday approved expanded use of Merck & Co Inc's antibiotic to treat hospital-acquired pneumonia in patients 18 years and older.


No comments:

Post a Comment